Skip to content

Reports

Revenue across every offering — how much we make, how many licenses and customers, and what's in flight. All from the revenue logged on each account.

Offering revenue

$1.1Mon the books

Licensed users

92seats sold

Customers

2using offerings

Offerings sold

2generating revenue

Contracts

44 active now

In progress

$3.1M10 open deals

Revenue by category

Revenue across offering categories.

$1.1Mtotal
Regulatory Information Management$960K
Global Regulatory Intelligence$150K

Revenue by type

Revenue by contract structure.

$1.1Mtotal
Project revenue (1)$220K
Annual service (1)$150K
License revenue (2)$740K

Top offerings

Contracted revenue remaining through upcoming renewals.

Freya.RegisterRegulatory Intelligence Services
Now90 days180 days1 year

Every offering, by revenue

Customers, revenue, licenses and contracts per offering.

OfferingCategoryCustomersRevenueLicensesContracts
Freya.RegisterRegulatory Information Management2$960K923
Regulatory Intelligence ServicesGlobal Regulatory Intelligence1$150K1

Renewals & contract terms

Every contract by end date — what's up for renewal soonest.

CustomerOfferingTypeRevenueEndsStatus
Helix BiologicsHelix BiologicsFreya.RegisterProject$220KAug 31, 202639d — renew soon
Helix BiologicsHelix BiologicsFreya.RegisterLicense$480KDec 31, 2026Active
Helix BiologicsHelix BiologicsRegulatory Intelligence ServicesService$150KDec 31, 2026Active
Meridian PharmaceuticalsMeridian PharmaceuticalsFreya.RegisterLicense$260KFeb 28, 2027Active

$1.4M weighted pipeline is still in progress on top of the $1.1M already on the books — see the forecast for the deal-by-deal view.